|
| 'Chitosan (1) | 1 (1) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 18 β-glycyrrhetic acid (1) | 2 (1) | 2, 5-diaza bicyclo [4.3.1] compounds (1) |
| 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) | 2-aminobenzothiazole (1) |
| 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) | 3 (2) |
| 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) | 32 factorial design (1) | 3D QSAR (1) |
| 3D-QSAR (1) | 3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) |
| 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) |
| 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) | 6-Mercaptopurine (1) |
| 6-Methylmercaptopurine (1) | 6-tetrahydropyridine (MPTP) (1) | 7-Hydroxy warfarin. (1) |
| 8-iso-Prostaglandin F2α (1) | A. nilotica (1) | ABC analysis (3) |
| ABC-VED matrix (4) | Abdominal Pregnancy (1) | Abheshaja (1) |
| Absorbance ratio (1) | Absorption ratio (1) | ABTS (1) |
| Abuse (1) | Academic Stressors scale (1) | Accuracy. (1) |
| Accurate (1) | ACE (1) | ACE inhibitor (1) |
| Aceclofenac (1) | Acetazolamide (1) | acetic acid induced writhing test (1) |
| Acetylcholinesterase (1) | Acetylcholinesterase inhibitors (1) | Acid-resistant capsules (1) |
| Acne (1) | Acne vulgaris (1) | Aconitine (1) |
| Acquired immune deÞ ciency syndrome (1) | Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) | Actinomycetes (1) |
| active pharmaceutical ingredient (1) | Active site (1) | Activities of daily living (ADL) scale (1) |
| Acupuncture (1) | Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) |
| Acute Inflammation (1) | Acute inß ammation (1) | Acute poisoning (1) |
| Acute toxicity (1) | acyclovir (2) | Adenanthera (1) |
| Adenosine A 2A antagonist (1) | Adherence (3) | Adiantum venustum (1) |
| ADR (2) | ADR management (1) | ADR monitoring centre (AMC). (1) |
| ADRs (1) | Adsorbent (1) | adverse drug events (1) |
| Adverse drug reaction (5) | Adverse Drug Reaction (ADR) (1) | Adverse Drug Reaction and Antihypertensive medications. (1) |
| Adverse drug reaction. (1) | Adverse Drug Reactions (5) | Adverse events (1) |
| Adverse reaction (1) | Aedes aegypti (1) | Aerobic exercise (1) |
| Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) | Age (1) |
| Ageratum conyzoides L (1) | air pollution (1) | Airjet (1) |
| Albendazole (1) | Albino wistar rats (1) | Alcohol (1) |
| alcoholic extract (1) | ALDEN (1) | Allergic rhinitis (1) |
| Allergy (2) | Alloxan (1) | Alloxan monohydrate (1) |
| Alocasia indica Schott (1) | Aloe vera (1) | Alpha-adrenoceptor (1) |
| alpha-delta-bungarotoxin-4 (1) | Alpinia speciosa (1) | Alprazolam (1) |
| Alteration of drug cost (1) | alternative therapy (1) | Alzheimer's disease (1) |
| Alzheimers disease (1) | Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) |
| Ambroxol hydrochloride (1) | Amides (1) | Amikacin Sulfate (1) |
| Amino acids (1) | amino benzylated Mannich bases (1) | amivudine (1) |
| Amlodipine (2) | Amlodipine besylate (2) | Ammonium salts (1) |
| Amoora cucullata. (1) | amoxicillin (1) | Amoxicillin sodium (1) |
| Anabolic. (1) | Analgesia (1) | analgesic (8) |
| Analgesic effect (1) | analgesic- anti-inß ammatory activity (1) | Analysis in capsules (1) |
| Analysis of variance (1) | Anaphylactic shock (1) | Anaphylaxis. (1) |
| and TGF–β (1) | Anemia (1) | Angiogenic growth factors (1) |
| antepartum (1) | anthelmintic (1) | anthelmintic property (1) |
| Anthracyclines (1) | Anti aging (1) | anti-anxiety activity (1) |
| Anti-asthmatic activity (1) | Anti-diabetes mellitus. (1) | Anti-epileptic drugs utilization (1) |
| Anti-HIV (1) | anti-hypertensive agent (1) | Anti-infective (2) |
| Anti-infective agents (1) | anti-inflammation (1) | anti-inflammatory (6) |
| Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) | anti-inflammatory activity (2) | anti-inflammatory activity', (1) |
| anti-inflammatory agent (1) | anti-inß ammatory (3) | Anti-inß ammatory activity (1) |
| Anti-obesity (1) | Anti-oxidant (1) | Anti-parkinsonism activity (1) |
| anti-spasmodic drug (1) | Anti-tumor agent (1) | antiamnesic agents (1) |
| Antianxiety (1) | antibacterial (3) | antibacterial activity (4) |
| Antibiotic (2) | antibiotic guidelines (1) | Antibiotic Resistance (2) |
| Anticancer (5) | Anticancer activity (1) | Anticancer drugs (1) |
| Anticholinergic (1) | Anticoagulant (1) | anticonvulsant activity (1) |
| anticonvulsants (1) | Anticovulsant (1) | Antidiabetic (2) |
| Antidiabetic activity (2) | Antidiabetic agents (1) | antiepileptic agents (1) |
| Antiepileptic Drugs (2) | antifungal (1) | antifungal activity (1) |
| Antigen (1) | antigen protein (1) | Antihistaminic (2) |
| Antihyperglycemic (1) | Antihypertensive (1) | Antihypertensives (1) |
| Antiinflamatory (1) | Antimalarial (1) | Antimicrobial (2) |
| Antimicrobial activities (1) | Antimicrobial activity (6) | Antimicrobial agent (1) |
| Antimicrobial efficacy (1) | Antimicrobial resistance (1) | Antimicrobial Stewardship (1) |
| Antimicrobials (3) | Antimosquito (1) | Antimycotic Activity (1) |
| antinociceptive (1) | Antioxidant (14) | Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) |
| Antioxidant activity (6) | antioxidant effect (1) | Antioxidant properties (1) |
| Antioxidants (5) | Antipsychotics (1) | antipyretic (2) |
| Antispasmodic (1) | Antithrombotic (1) | Antithyroid drugs (1) |
| antiulcer (1) | Antivenom (1) | Antivenom reactions (1) |
| Antiviral (1) | antiviral activity (1) | Antiviral RNA (1) |
| Anxiety (2) | APAP (1) | APC (1) |
| Apoptosis (1) | Application to PK profile studies (1) | applications (1) |
| Appropriateness (1) | Aqueous extract (3) | AR Caps (1) |
| ARDS (1) | Area above the blood glucose levels-time curve. (1) | area of wound healing (1) |
| Areca nut (1) | Arginine (1) | ART (1) |
| Artemia salina (1) | Artemisia macrocephala (1) | arterial hypertension (1) |
| Arteriovenous malformation (AVM) (1) | Arthritis (1) | Ascorbic acid (3) |
| Asenapine (1) | asian developing nations (1) | Aspergillus niger (1) |
| Aspergillus niger. (1) | Aspergillus terreus (1) | Aspirin (1) |
| Assay (2) | Asthma (4) | Asymptomatic neurocognitive impairment (1) |
| Ataxia (1) | ATC/DDD (3) | Atherosclerotic Vascular Disease (1) |
| Atorvastatin (5) | Atorvastatin calcium (1) | Atorvastatin. (1) |
| ATP synthase inhibitor (1) | ATP- sensitive K+channel (1) | Atrial fibrillation (1) |
| Attitude (6) | Attitude and practice (1) | Attitude. (1) |
| Authors (1) | Authorship issues (1) | Autism spectrum disorders (1) |
| Auto antibody (1) | Autoimmune disorders (1) | Autoimmunity (1) |
| Avicel (1) | Awareness (2) | Ayurveda (1) |
| Azilsartan medoxomil (1) | Bacoside A3 (1) | Bacterial isolates (1) |
| Bacteriological culture (1) | Bacteriostatic (1) | Bangladesh (2) |
| bark (1) | Barleria cristata (1) | Barriers (1) |
| Bauhinia racemosa (1) | Bauhinia variegata (2) | Bay-K-8644 (1) |
| Bayesian confidence propagation neural network (1) | BCS-IV drug (1) | Beck Depression Inventory (1) |
| Beck Depression Inventory(BDI) (1) | Bedaquiline (1) | Belief (1) |
| benzimidazoles (2) | Benzothiazole analogues (1) | Bibliometrics (3) |
| Bioactive Metabolites (1) | Bioadhesive (1) | Bioanalytical method (1) |
| Bioanalytical method development (1) | Bioassay (1) | bioavailability (5) |
| Biodegradable (1) | Biohazard (1) | Biologics (1) |
| Bioprospecting. (1) | Biopsy Proven Acute Rejection (1) | Biosafety Engineering Control (1) |
| Bitter (1) | Black tea extract (1) | Bleeding time (1) |
| Bleomycin (1) | Blonanserin (1) | Blood brain barrier (1) |
| Blood glucose (1) | Blood pressure (2) | Boerhaavia Diffusa (1) |
| Bone (1) | Book Review (1) | Borg scale (1) |
| botulinum toxin (1) | Box-Behnken (1) | Brahmi vati (1) |
| Brain (1) | brand name drugs (1) | Branded medication (1) |
| Bratton-Marshall reagent (1) | Breast cancer (4) | Brewer’s yeast (1) |
| Brief COPE scale (1) | Brief medication questionnaire (1) | Brimonidine tartrate (1) |
| brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) | Bromelain (1) |
| Bromeliaceae (1) | Bromocresol purple (1) | Bronchial Asthma (1) |
| Bryonia laciniosa (1) | Buccal (1) | Buccal Patches (1) |
| budget forecasting (1) | Bufadienolide (2) | Bullous eruption (1) |
| bungarotoxin (1) | Bungarus caeruleus (1) | Buoyant microspheres (1) |
| Burden Of Disease (1) | Business method (1) | Business model (1) |
| Butea monosperma (1) | C934 (1) | Ca2+ channels (1) |
| Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) | Calcium (1) |
| Calcium channel blocking (1) | calcium channel blocking activity (1) | Calcium oxalate (1) |
| Calcium silicate (1) | Calendula officinalis (1) | calendula oil (1) |
| Camellia sinensis (1) | Camptothecin (1) | Cancer (2) |
| Cancer Chemotherapy (2) | Candida (1) | Candida albicans (1) |
| Candida albicans. (1) | Capacity (1) | Capsule (1) |
| capsules (1) | carbamazepin (1) | Carbamazepine (2) |
| carbohydrazide (1) | Carbomyl Linkage (1) | carbon tetrachloride (1) |
| carbonyl compounds (1) | Carbopol 940 (1) | cardiac arrhythmias (1) |
| Cardiology (1) | Cardioprotective (1) | Cardiotoxicity (1) |
| Cardiovascular disease (1) | Carnauba wax (1) | carrageenan (2) |
| Caryocar coriaceum (1) | Case report (1) | Casein (1) |
| Casein Phosphopeptide-amorphous calcium Phosphate (1) | catalepsy (2) | CationicGuargum (1) |
| Causality assessment (2) | Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) |
| Cefixime (1) | ceftriaxone and co-amoxiclav (1) | Cefuroxime Axetil (1) |
| cell viability Glycyrrhiza glabra (1) | Cellulase (1) | Cemented (1) |
| Cementless (1) | CEN (1) | Centella asiatica (2) |
| Central composite design (4) | Cephalexin (2) | Cerebrovascular Accident (1) |
| Cervical dentine hypersensitivity (1) | CFFF (1) | chalcone (1) |
| chalcones (1) | Characterization (2) | Chemical stability (1) |
| Chemometrics (2) | Chemotherapy (3) | Chewing gum (1) |
| Children (1) | Children Dentistry (1) | Chitosan (6) |
| Chitosan Acetate. (1) | chitosan microspheres (1) | Chitosan-g-HPβCD (1) |
| Chlamydomonas reinhardtii (1) | Chlorhexidine (2) | Chlorohexidine (1) |
| cholesterol (1) | Cholinesterase inhibitors (1) | Chromotropic acid reagent (1) |
| Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) | Cinnamaldehyde (1) |
| Cinnamomum cassia (1) | Ciprofloxacin (1) | Citrus hystrix (1) |
| Citrus limon (2) | CKMB. (1) | Claims (1) |
| Clarithromycin (1) | Cleistanthin A (2) | cleistanthin B (2) |
| Cleistanthus Collinus (1) | Clinical attachment level (1) | Clinical equivalence (1) |
| Clinical manifestation (1) | Clinical pharmacology (1) | Clinical research (1) |
| Clinical trial (1) | Clinical trials (1) | Clinicians (1) |
| clonidine (2) | Clopidogrel (1) | Closed melt (1) |
| cloxacillin (1) | Cluster analysis (1) | CME (1) |
| Co-crystal (1) | Co-Morbidity (1) | co-precipitation method (1) |
| Co-surfactant (1) | Cochlopermum tinctorium (1) | coding system (1) |
| Cognition (2) | Cogrinding (1) | Colloidal carriers (1) |
| Colloidal silicone dioxide (1) | Colon targeted delivery (1) | Colon targeted drug delivery. (1) |
| Colonic delivery (1) | colorimetric assay (1) | Combination tablet (1) |
| Combination Therapy (1) | Combinatorial effect (1) | Comet assay (1) |
| common cold (1) | Common warts (1) | Community Pharmacies (1) |
| comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) | compensation (1) |
| Complementary and alternative medicine (1) | complementary and alternative medicines (1) | complete epithelization (1) |
| Compliance (1) | compound 48/80 (2) | compritol 888 ATO (1) |
| Computer (1) | computer-aided instructions (1) | Computer-aided learning (1) |
| Computerized screening systems (1) | CoMSIA (1) | Constipation (1) |
| Consumer (1) | Consumer perception (1) | content validity (1) |
| continuing education (1) | Contract research (1) | Contract research organizations (1) |
| Controlled release (4) | convolution (1) | convulsions (1) |
| cooperative practice (1) | COPD (2) | Cordia obliqua (1) |
| Corneal opacities (1) | Coronally advanced flap (1) | Correlation (2) |
| Cosmetic (1) | Cost avoidance (1) | Cost of illness (1) |
| Cost saving (1) | Cost. (1) | Cotton oil (1) |
| cotton pellet (1) | Cough (1) | Cough medicine (1) |
| cough. (1) | Counterfeit Pharmaceutical Products (1) | Cramer’s Matrix method (1) |
| CRC (1) | creatinine (1) | Critical Care Unit (CCU) (1) |
| Critical Thinking (1) | cromolyn sodium (1) | Croscarmellose sodium (CCS) (1) |
| Crospovidone (1) | Crospovidone (CP) (1) | Cross carmellose sodium (1) |
| cross-linking agents (1) | Crossandra (1) | Croton zehntneri (2) |
| Crystallinity (2) | CTEPH (1) | Cucumis metuliferus (1) |
| Cucumis sativus (1) | CUMIN. (1) | Cuminosides (1) |
| Curcuma longa (1) | Curcumin (2) | current indian scenario of drug interactions (1) |
| curriculum development (1) | Cyclooxygenase (1) | cyclophosphamide (1) |
| Cymbopogon citratus (1) | Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) |
| Cyst (1) | Cytochrome P 2C9 (1) | Cytotoxic (1) |
| Cytotoxic activity. (1) | Cytotoxic agents (1) | Cytotoxicity (2) |
| CZE (1) | D&C (1) | D-optimal design (1) |
| Daily Defined Dose (1) | Dapsone (1) | DDX3 (1) |
| Death Receptors (1) | Decision making (1) | Degradation (1) |
| Delignification (1) | Delirium (1) | democratic government (1) |
| Dengue high fever (1) | Dental caries (2) | Dental Caries. (1) |
| dental management (1) | Dental Students (1) | dentistry. (1) |
| Deodorants (1) | Dependence (1) | Depigmentant (1) |
| Depok Primary Health Care (1) | Depression (1) | Design of experiments. (1) |
| desirability function (1) | Desirability index. (1) | Desmodium gangeticum (1) |
| Detorsion (1) | device safety (1) | dexamethasone (2) |
| Dexibuprofen (1) | Diabetes (3) | diabetes and diabetic vascular complications (1) |
| Diabetes mellitus (9) | diabetes mellitus, (1) | Diabetes Type-II (1) |
| Diabetes, glucose (1) | diabetic dyslipidemia (1) | Diabetic nephropathy (1) |
| Diabetic retinopathy (1) | Diacerein (1) | DiaKure (1) |
| diclofenac (1) | Diclofenac SLN (1) | Diclofenac sodium (1) |
| Dicots (1) | Dicyclomine (1) | differential scanning calorimetry (1) |
| diffuse transmittance (1) | Dillenia indica (2) | Dilleniaceae (1) |
| Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) | Dimethylpyrimidin-derivatives (1) |
| Dip coating (1) | Diplotropis ferruginea (1) | direct compression (3) |
| Direct to consumer advertising (1) | Discharge against medical advice (DAMA) (1) | discharge orders (1) |
| Discrepancies (1) | Discriminant analysis (1) | Disease (1) |
| disintegration (1) | disintegration time (1) | Dissolution (4) |
| dissolution enhancement (1) | Dissolution rate (1) | Diuretic (1) |
| Diuretic activity (2) | DMAIC (1) | DNA damage (1) |
| DNA fragmentation (1) | docking (2) | docking. (1) |
| Doctor (1) | Documentation and records (1) | Donepezil hydrochloride (1) |
| Dopamine (1) | Dosage formulation (1) | Dosage regimen (1) |
| Dose-dependent (1) | DOTS plus (1) | Doxorubicin (1) |
| Doxycycline (1) | DPPH Assay (1) | DPPH scavenging (1) |
| DRcaps (1) | DREEM. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) |
| droplet size (1) | Drug (2) | Drug detailing (1) |
| drug disposal (1) | Drug Hypersensitivity (1) | Drug Information and Literature Evaluation (1) |
| drug interaction (2) | Drug interaction (DI) (1) | drug interaction management (1) |
| drug interactions (1) | Drug product (1) | Drug Related Problems (2) |
| drug release (1) | Drug safety (2) | Drug Safety. (1) |
| Drug utilization (1) | drug utilization study (1) | drug-drug interactions (3) |
| Drug-SLS tablets. (1) | Drugedrug interaction (1) | Drugs (1) |
| drug–drug gliclazide (1) | Drug–drug interaction (1) | Dry extract cinnamon (1) |
| DSPC (1) | Dual Therapy (1) | dual-target-directed drugs (1) |
| Dunaliella salina (1) | Dysphagia (1) | e-prescribing (1) |
| E. coli (1) | EC50 values (1) | Economic (1) |
| Edaravone (1) | Eddy’s hot plate method. (1) | edema (1) |
| Editorial (22) | Education (2) | Educational excellence (1) |
| efavirenz (2) | Efficacy. (1) | EGCG (1) |
| egg albumin microspheres (1) | Elderly (1) | Elderly Patients (1) |
| Electrochemical (1) | electrolyte release (1) | electrolytes (1) |
| Electroporation (1) | Elevated plus maze (1) | elevated plus maze model (1) |
| Emblica offi cinalis (1) | Emergency contraception (1) | Emotional (1) |
| Emulsification and Solvent Evaporation (1) | emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) |
| Encholirium spectabile (1) | Endocrine disruptor (1) | Endophytes (1) |
| Endothelial cells (1) | endothelial Nitric Oxide Synthase (1) | Endothelial progenitor cells (1) |
| Enicostemma littorale (1) | Entire plant (1) | entrapment efficiency (2) |
| Envenoming (1) | Environmental Factors (1) | eosinophil (1) |
| Epigallocatechin Gallate (1) | Epigenetics (1) | epilepsy (4) |
| erbal drugs (1) | erice declaration (1) | Erythrina indica (1) |
| erythropoietin (1) | Escherichia coli (1) | Escitalopram oxalate (1) |
| esomeprazole (1) | Essential hypertension (2) | Essential medicine (1) |
| essential medicines (1) | essential oil (3) | essential oil composition (1) |
| Essential principles (1) | Estimated Glomerular Filtration Rate (1) | Ethanol (1) |
| ethanolic extracts (1) | Ethiopia (2) | ethnicity (1) |
| Ethosomes (1) | Ethyl - 4- acetamido phenoxy acetate (1) | Ethyl acetate (1) |
| ethyl cellulose (2) | ethylcellulose (1) | ethylene glycol (2) |
| Eucalyptus hybrid (1) | Eucalyptus oil (2) | eudragit (1) |
| Eudragit RL 100 (1) | eudragit S100 (2) | Eudragit-L100 (1) |
| Eudragit® S100 (1) | Eugenol (1) | Euphorbia hirta leaves (1) |
| Eurycoma Longifolia Jack (1) | Ex-vivo permeation (1) | Excision wound model (1) |
| experiences (1) | Exports (1) | Expression profile (1) |
| Extract (1) | Extrapyramidal side-effects (1) | extrinsic stains (1) |
| extrusion (1) | Ezetimibe (2) | Fabaceae (2) |
| factorial design (5) | Factors associated with medication non-adherence (1) | Falcipain-2 (1) |
| Family satisfaction (1) | family therapy (1) | famotidine (2) |
| fast disintegrating tablet (1) | Fast Disintegrating Tablets. (1) | Fast dissolving films (1) |
| Fast dissolving tablets (1) | Fasting serum insulin level (1) | Fat (1) |
| Fatty acid profile (1) | FC reagent (1) | FDA Approval (1) |
| Fenugreek (1) | Ferritin (1) | Ferrous sulfate (1) |
| Fialuridine', (1) | Ficus bengalensis (1) | Ficus bengalensis (Moraceae) (1) |
| Ficus racemosa (1) | film (1) | film hydration (1) |
| First permanent molars (1) | Fixed drug eruption (1) | Flavonoid (1) |
| Flavonoid Compounds (1) | flavonoids (2) | Flavoxate HCl (1) |
| FlK-1 (1) | Floating beads (1) | floating controlled drug-delivery system (1) |
| Floating drug delivery system (1) | floating lag time (1) | fluoroquinoes (1) |
| Fluoxetine (1) | Flupritine maleate (1) | flurbiprofen (1) |
| Flux (1) | folkloric use (1) | Food drug and cosmetic act (1) |
| Forced degradation (3) | Forced degradation studies (1) | forced swim test (1) |
| Formulary (1) | Formulary. (1) | Formulation (1) |
| Formulation and development (1) | Fourier transform infra red spectroscopic (1) | FPGEE (1) |
| Fraction (1) | Franz Diffusion Cell (1) | free radical scavenger (1) |
| Free radicals. (1) | Freund’s complete adjuvant (1) | Fructo-Oligosaccharide (FOS) (1) |
| Frusemide (1) | Frusemide-induced complications (1) | FTIR (5) |
| Fumes (1) | furosemide (1) | Galacto-Oligosaccharide (GOS) (1) |
| gallic acid (2) | Gamma irradiation (1) | Gangrenous (1) |
| Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (2) |
| Garcinia imberti bourd (1) | Garcinia indica (1) | Garcinia latissima (1) |
| gaseous contact (1) | gastric treatment (1) | Gastro-retentive drug delivery system (1) |
| gastroprotection (2) | gastroretentive (1) | gastroretentive drug delivery system (1) |
| Gatot Soebroto hospital. (1) | GC-MS (1) | GC-MS analysis (1) |
| Gelatin (1) | gemfibrozil (1) | Gender (1) |
| Gene silencing (1) | Generic (2) | generic drugs (1) |
| Generic medicines (2) | Generic name. (1) | Generic substitution (1) |
| Generics (1) | Genetic polymorphisms (1) | genetic Signature (1) |
| Genotype frequency (1) | Gentamicin (3) | gentamicin sulfate (2) |
| Geriatrics (3) | GFAP (1) | Gibb’s reagent (1) |
| Ginger (1) | Gingival hyperplasia (1) | Gingival hypertrophy (1) |
| gingival pocket (1) | Gingival recession (1) | Gingival thickness (1) |
| glibenclamide (3) | gliclazide (2) | Glimepiride (1) |
| glimepride (1) | Glipizide (3) | glitazars (1) |
| Global education (1) | Glucagon (1) | Glucocorticoids (1) |
| Glucose (1) | glucose tolerance test (1) | glutathione (1) |
| Glycerine (1) | Glycine max (1) | Glycosylated hemoglobin (HbA1c) (1) |
| Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) | Goal orientation (1) |
| Goldenhar syndrome (1) | good manufacturing practices (1) | Graft Survival (1) |
| Grafting (1) | Gravimetry (1) | Grazing angle X-ray diffraction (1) |
| Green tea (1) | Green Tea Leaves Extract (1) | Griseofulvin (1) |
| GSH (1) | guanyl cyclase stimulator (1) | Guest Editorial (1) |
| Guidelines (1) | Gulf cooperation council (1) | Gum and fat fractions (1) |
| Gymnema Sylvestre (1) | GYTS (1) | H+ (1) |
| H-460 (1) | H2 Receptor Antagonist (1) | Haematological (1) |
| Haemolytic ratio. (1) | Hair Growth Activity (1) | Hair Tonic (1) |
| Hajj (1) | haloperidol (1) | hardness (1) |
| harmacotherapy-based problems (1) | Harmonization (2) | Hazardous drugs (1) |
| HBV (1) | HCT: Hydrocholrothiazide. (1) | head twitch (1) |
| Health benefits (1) | Health care profession (1) | health care professionals (1) |
| Health care. (1) | Health Hazard (1) | Health informatics (1) |
| Health problems (1) | Health Services Accessibility (1) | Healthcare (4) |
| healthcare communication (1) | Healthcare Delivery (1) | healthcare expenditure (1) |
| Healthcare Professionals (1) | healthcare providers (1) | Healthy volunteers (1) |
| heart failure (1) | Hematological parameters (1) | hematological toxicity (1) |
| Hematology (2) | Hematoma (1) | hepatoprotective (2) |
| hepatoprotective activity (3) | Hepatotoxicity (1) | HER1 (1) |
| HER2 (1) | HER3 (1) | HER4 (1) |
| Herbal active ingredients (1) | Herbal medications (1) | Herbal medicine (1) |
| herbal medicines (1) | HET-CAM (1) | Heterocyclic compound (1) |
| Heterotopic Pregnancy (1) | Hex (1) | Hexane (1) |
| Hibiscus cannabinus Linn. (1) | Hibiscus rosa. (1) | High fat diet (1) |
| High Fat Diet Model (1) | high performance liquid chromatography (1) | high performance thin layer chromatography (1) |
| High-density lipoprotein cholesterol (1) | High-fat diet (1) | high-performance liquid chromatography (2) |
| High-throughput screening (1) | Higher education (1) | highly active antiretroviral therapy (1) |
| Highly Cited Papers (1) | Himatanthus drasticus (1) | Hip Arthroplasty (1) |
| Hirsutism (2) | Histocompatibility. (1) | Histological studies. (1) |
| Histopathology (2) | HIV (1) | HIV associated dementia. (1) |
| HIV-associated neurocognitive disorder (1) | HL-60 and K-562 (1) | HMG-CoA Reductase (1) |
| homology modeling (1) | Honeycomb (1) | Hordeum vulgare (1) |
| Hordeum vulgare hull (1) | hospitalized children (1) | hospitalized patients (1) |
| Hospitals (1) | host (1) | hot plate (1) |
| HP-ß Cyclodextrin complexes (1) | HPLC (7) | HPLC (High Performance Liquid Chromatography) Ornidazole (1) |
| HPLC method validation (1) | HPLC. (1) | HPMC (1) |
| HPMC capsules (1) | HPMC K100M (1) | HPMC K4M (1) |
| HPTLC (5) | HRQoL (2) | HSV-1 (1) |
| Human breast cancer cells (1) | Human breast cancer MCF -7 cells (1) | human immunodeficiency virus (2) |
| human immunodeÞ ciency virus (1) | Human Papillomavirus (1) | Human plasma (2) |
| human plasma level (1) | Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) | Humanitarian device exemption. (1) |
| Hydralazine hydrochloride (1) | Hydroalcoholic (1) | hydrochlorothiazide (1) |
| Hydrochlorthiazide (1) | hydrogel (1) | hydrogen sulfide (1) |
| hydrogenated castor oil (1) | Hydrophilic drugs (1) | Hydrophillic sealants (1) |
| Hydrophobic sealants (1) | hydroxy propyl methyl cellulose (1) | Hydroxyl radical (1) |
| hydroxypropyl cellulose (1) | hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose E15 (1) |
| Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) | Hydroxypropylmethylcellulose (1) |
| Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) | Hypercholestremia (1) |
| Hyperglycemic (2) | Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) |
| hyperoxaluria (1) | hypertension (4) | Hypertension( HTN) (1) |
| Hypertensive’s (1) | Hyperthyroidism (1) | hypertriglyceridemia (2) |
| Hyperzincuria (1) | hypoglycemic (1) | Hypoglycemic activity (1) |
| hypolipidemic (1) | Hypothyroidism (1) | Hypozincaemia (1) |
| IBD - Inflammatory Bowel Disease (1) | IC50 (2) | ICH (2) |
| ICH guidelines (2) | ICP22 (US1) gene (1) | IL-17 (1) |
| IL-6 (1) | IL-MAE (1) | Illiterate (1) |
| Iloperidone (1) | image analysis (1) | imidazole (1) |
| Immune response (1) | immunocytochemistry (1) | In silico (2) |
| in situ gelation (1) | in vitro (3) | In vitro kinetics (1) |
| In vitro Penetration Test. (1) | In vitro release (1) | In vitro–In vivo (1) |
| in vivo (1) | In vivo kinetics (1) | In-patien (1) |
| in-vitro dissolution study (1) | In-vitro skin permeation (1) | inclusion complexes (2) |
| indexed cost (1) | India (7) | India. (1) |
| Indian context (1) | Indian Traditional medicine (1) | Indion 234 (2) |
| Indion resin (1) | indomethacin (2) | Indonesian National Health Insurance (1) |
| Industry (1) | Inequality (1) | infarct size (1) |
| infective endocarditis (1) | infertility (1) | inflammation (2) |
| inflammatory bowel disease (2) | Information need (1) | Information system (1) |
| Information Technology Officers (1) | Information tool (1) | innovation ecosystems (1) |
| inorganic salts. (1) | inß ammation (2) | inß ammatory bowel diseases (1) |
| Insilico anticancer screening (1) | insulin (3) | Insulin receptor (1) |
| Insulin regimen (1) | insulin resistance (1) | Insulin resistance. (1) |
| insulin use in primary care (1) | Insulinophobia (1) | Integrase inhibitor (1) |
| Integrated Courses (1) | integrated economic analysis (1) | Intellectual Property l (1) |
| Intellectual property rights (1) | intelligent tutoring (1) | Intensive care unit (1) |
| Intensive Care Unit (ICU) (1) | Intensive Monitoring (1) | interaction (2) |
| interferon (1) | interleukins (1) | International Collaboration (1) |
| International HIV dementia scale (IHDS) (1) | international organization (1) | international organizations (1) |
| international trade (1) | Internet (1) | interpretation (1) |
| Intracanal medicament (1) | intraocular presuure (1) | Intrauterine Pregnancy (1) |
| inventory management (3) | investigators (1) | Invited Article (2) |
| ion pair complex (1) | Ionic liquid (2) | ionic liquid-based microwave-assisted extraction (1) |
| ionotropic gelation (1) | iontophoresis (2) | Iraq (1) |
| Iridoid glycoside (1) | Irvingia gabonensis (1) | isatin (3) |
| ischemia (1) | ischemia-reperfusion injury (1) | Ischemic (1) |
| ischemic heart disease (1) | ISO (1) | isoniazid (1) |
| isonicotinohydrazide (1) | Isopropyl myristate (1) | isoproterenol (1) |
| isoxazoline (1) | itopride HCl (1) | JNC 8 Guidelines. (1) |
| Journal (1) | Jurkat (1) | K+-ATPase β subunit (1) |
| K+ATP channel (1) | K-CAPS (1) | K562 (1) |
| Kaffir lime (1) | Kajjali (1) | Kalanchoe Pinnata (2) |
| KAP (1) | KAP study (1) | Kappa. (1) |
| Karachi (2) | Kathakakhadiradi kashyam (1) | Kernel powder (1) |
| Ketorolac (1) | Ketorolac salt (1) | Key words: 5-FU (1) |
| Key words: Esomeprazole (1) | kidney (2) | kinetic drug release (1) |
| Kinetic Modelling (1) | KMnO4 (1) | kneading method (1) |
| kneading technique (1) | knowledge (7) | L-Thyroxine (1) |
| labeling (1) | Laboratory findings. (1) | Lactobacilli (2) |
| Lactobacillus (1) | Lag period (1) | Lagenaria siceraria (1) |
| Lantana camara (1) | Lantana montevidensis (1) | Larvacidal (1) |
| LC/MS/MS (1) | LCMS/MS (1) | LC–MS/MS (1) |
| LDL-C (1) | leaves (4) | Leftover medicines, (1) |
| Leg Length (1) | Leptin (1) | Letter to Editor (4) |
| Letter to the Editor (3) | Letters to the Editor (6) | Leucaena leucocephala (1) |
| Leucas lavandulaefolia (1) | Levocetirizine (1) | Licofelone (1) |
| Ligand-based drug design (1) | Lightening (1) | Limb Length (1) |
| lime fruit (1) | lipid matrix (1) | lipid metabolism (1) |
| lipid microspheres (1) | Lipid nanocrystals (1) | Lipid peroxidation (3) |
| lipid peroxides (1) | lipid profile (1) | Lipid profile membrane bound enzymes (1) |
| lipids (1) | lipoic acid (1) | liposome (1) |
| Lippia (1) | lithium toxicity (1) | Live-well™ (1) |
| liver function (1) | Liver necrosis (1) | Liver Transplantation (1) |
| locomotor activity (1) | Low-density lipoprotein cholesterol (1) | Lozenges (1) |
| Luffa echinata (1) | Luminesce (1) | Lung (1) |
| Lung cancer (1) | Lupenoic acid (1) | Lycatab C (1) |
| Macromicroscopy study (2) | Major Contributed Organizations (1) | Malaysia (2) |
| Malaysia. (1) | Malaysian. (1) | malondialdehyde (2) |
| Mammary carcinoma (1) | Mandibular hypoplasia (1) | Mangosteen Peels (1) |
| manidipine dihydrochloride (1) | Mannich base (1) | Mast cell (1) |
| Matrix Tablet (1) | matrix tablets (3) | MCF-7 (1) |
| MDA (1) | MDR-TB (2) | mean age (1) |
| mechanisms (1) | Meclizine HCl (1) | Medical (1) |
| medical costs (1) | Medical device (1) | Medical device recalls (1) |
| medical errors (1) | Medical informatics (1) | Medical Inpatients (1) |
| Medical practitioner (1) | Medical Representative (1) | Medical sales representative (1) |
| Medical students (2) | medication adherence (3) | medication adherence behaviour (1) |
| medication error (1) | Medication errors (1) | Medication non-adherence (1) |
| Medication reconciliation (1) | Medication regimen complexity (1) | medication safety (1) |
| medication-/drug-related problem (MRP/DRP) (1) | Medicinal plants (1) | Medicine (2) |
| medicine-use practices (1) | Melinjo (2) | Meloxicam (1) |
| Memory (1) | Memory and learning. (1) | Mentha arvensis (1) |
| mesalamine (1) | Metabolic ratio (1) | Metabolic syndrome (1) |
| Metabomics (1) | metagenomic (1) | metformin (6) |
| metformin hydrochloride (1) | Methanol (1) | methanolic extract (1) |
| methocel (1) | method development (2) | method validation (3) |
| Methotrexate (1) | methyl orange (1) | methyl-b cyclodextrin (1) |
| metoprolol tartarate (1) | MetS (1) | Mevalonate (1) |
| Micro emulsion (2) | Micro particles. (1) | Micro-emulsion (1) |
| microbial contamination (1) | Microbiological (1) | Microbroth dilution (1) |
| microcrystalline cellulose (3) | microdilution (1) | Microdosing (1) |
| microneedles (1) | Micronucleus assay (1) | microparticles (1) |
| microsphere (1) | microspheres (6) | microtriches (1) |
| Microwave assisted extraction (1) | Microwave-Assisted Extraction (1) | miglitol (1) |
| Migraine (2) | migraine management, (1) | Mild neurocognitive disorder (1) |
| Milk (1) | Milnacipran (1) | Mimosa pudica (1) |
| minimal inhibitory dose (1) | Minimum Inhibitory Concentration (MIC) (1) | mismatches (1) |
| mitochondria (1) | Mix mode (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) |
| modern medicine (1) | modified melt dispersion technique (1) | Modified Starches (1) |
| Mol inspiration (1) | Molecular characterization (1) | Molecular docking (4) |
| molecular docking and anti cancer activity. (1) | Molecular Docking. (2) | Molecular mimicry (1) |
| monoamine oxidase B (1) | Monocots (1) | montelukast (2) |
| montelukast sodium (1) | Montelukast, (1) | moraceae (1) |
| Morin and validation (1) | Moringa oleifera (2) | Moringa oleifera. (1) |
| Morisky medication adherence questionnaire (1) | Mortality (2) | Mouth Dissolving Tablets (1) |
| mouth-dissolving film, (1) | MPTP (1) | MTT Assay (2) |
| MTT method (1) | MUC2 (1) | MUC6 (1) |
| Mucoadhesive (1) | Mucoadhesive agent (1) | mucoadhesive formulation (1) |
| Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) | mucodhesive (1) |
| multi granules (1) | multidrug resistant pathogens (1) | multiparticulates (1) |
| multiparticulates dosage form (1) | multiple regression (1) | multiple regression analysis (1) |
| Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) | Mycobacterium tuberculosis. (1) |
| Mycophenolate mofetil (1) | Mycophenolic acid (1) | myocardial infarction (1) |
| Myomectomy. (1) | Myrica esculenta (1) | N-aminoimidazoles (1) |
| N-napthyl ethylene diamine dihydrochloride (1) | Na+/K+-Atpase (2) | NABP (1) |
| Naftopidil (1) | nano size (1) | Nanoformulation (1) |
| nanoformulations (1) | Nanonization. (1) | Nanopacticle (1) |
| Nanoparticle (1) | Nanoparticles (6) | Nanosuspension (1) |
| Nanosuspension tablets (1) | Nanosuspensions (1) | Naphthoquinone derivative (1) |
| NAPLEX (1) | naproxen (1) | Naranjo (1) |
| Naranjo algorithm (1) | Naranjo algorithm. (1) | Naranjo’s ADR probability scale (1) |
| Narikel Lavan (1) | Nasal gel (1) | Nateglinide (1) |
| National Fomulary (1) | National Formulary (2) | National Public Health Programs (1) |
| natural compounds (2) | Natural Polymers (1) | natural products (2) |
| NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (1) | nebivolol hydrochloride (1) |
| Necrosis. (1) | need assessment (1) | Nephroprotective (2) |
| Nephrotoxicity (1) | Nerium indicum (1) | neuropathy (1) |
| Neurosurgical (1) | neutropenia (1) | nevirapine (1) |
| new molecule (1) | Nicorandil (1) | Nicotine dependence (1) |
| Nifedipine. (1) | Nigeria. (1) | nigrostriatal pathway (1) |
| Nil (6) | Nill (18) | niosome (1) |
| Niosomes (1) | Nitric acid (1) | Nitrogen starvation (1) |
| NMDA (1) | NMDA receptors (1) | Nodular skin lesions (1) |
| Non-linear (1) | non-prescription medicine use (1) | nonamers. (1) |
| noncommunicable disease (1) | noncompliance (1) | Nonionic surfactants (1) |
| nootropic (1) | Norfloxacin (1) | Normoglycemic rats (1) |
| northeast India (1) | Nose to brain delivery (1) | Nothopanax scutellarium (1) |
| Nuclear medicine (1) | nuclear pharmacy (1) | Nucleo CMP (1) |
| Nude mice (1) | Nutraceuticals (1) | Nutrient starvation (1) |
| Nutrition (1) | Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) |
| Obesity (1) | Occupational health (1) | Ocimum gratissimum (1) |
| Off-label (1) | offending drugs (1) | Okra Mucilage (1) |
| Olmesartan (1) | olmesartan medoxomil (1) | Omeprazole. (1) |
| Omics (1) | Oncology. (1) | ondansetron (3) |
| ondansetron hydrochloride (1) | OPD – Outpatient Department. (1) | open field (1) |
| ophthalmic delivery (1) | ophthalmic inserts (1) | Opportunities (1) |
| Optimal stress (1) | optimization (7) | Oral cancer (1) |
| oral disintegrating tablets (1) | Oral glucose tolerance (1) | oral glucose tolerance test (3) |
| oral insulin (1) | Oral Rehabilitation (1) | organic acids (1) |
| organogel (1) | Origanum vulgare (1) | Original Article (3) |
| Originator. (1) | Orlistat (1) | orodispersible tablet (1) |
| orodispersible tablets (2) | Osmotic pump (1) | Osteoblast (2) |
| Osteoclast (1) | OTC switch (1) | Otomycosis (1) |
| Outdoor patients (1) | Outpatients (1) | ovalbumin (1) |
| Ovarian (1) | OVX (1) | oxazepinone (1) |
| oxcarbazepine (1) | oxidative damage (1) | oxidative stress (6) |
| oxytetracycline (1) | P-dimethylaminobenzaldeyde (1) | P-drug. (1) |
| P-drugs (1) | P-glycoprotein (1) | P. dulce (Fabaceae) (1) |
| p53 tumor suppressor gene (1) | Package insert (1) | Paediatric (2) |
| Pain (1) | pair wise procedures (1) | Pakistan (2) |
| Pakistan. (4) | Paliperidone palmitate (1) | Pancreatitis. (1) |
| Pantoprazole (1) | papain (1) | PAR-2 receptor (1) |
| para-diaminobenzaldehyde (1) | paracetamol (2) | Paracetamol. (1) |
| partial least square (1) | particle size analysis (1) | PASS (1) |
| passive avoidance learning (1) | patents (2) | Pathological response (1) |
| Patient (2) | Patient adherence. (1) | patient counseling (1) |
| patient education (1) | Patient health questionnaire (PHQ) (1) | Patient Survival (1) |
| patient-physician communication (1) | Patient-safety (1) | patients (2) |
| Patients. (1) | paw edema (1) | Paw edema. (1) |
| Paw volume (1) | PE 18:0/18:0-PEG 2000 (1) | Pectin (1) |
| pedagogy (1) | Pediatric (1) | Pediculosis (1) |
| PEGylation (1) | Penang (1) | penetration (1) |
| penetration enhancer (1) | penetration pressure (1) | pentylenetetrazole (1) |
| PEO (1) | Peperomia pellucida (L.) Kunth (3) | Peppas and Higuchi’s equations (1) |
| Peptic Ulcer. (1) | peptide vaccine (1) | percentage healing of wound area (1) |
| perception (3) | Periauricular tags. (1) | pericyclic fiber (1) |
| Periodontal disease (1) | periodontal diseases (1) | periodontal pocket (1) |
| Peripheral Neuropathy (1) | Permeation (1) | Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) |
| Personal care products (2) | pH dependent approach (1) | pH independence (1) |
| pH-sensitive (1) | Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) |
| pharma counseling (1) | pharmaceutical (1) | pharmaceutical advertisements (1) |
| Pharmaceutical care (1) | pharmaceutical care. (1) | pharmaceutical formulations (1) |
| Pharmaceutical Marketing (1) | Pharmaceutical Services (1) | Pharmaceutical-Care (1) |
| Pharmaceutical-industries (1) | Pharmacist (4) | Pharmacist intervention. (1) |
| pharmacist role in public health (1) | Pharmacists (1) | pharmacists India (1) |
| Pharmacodynamic (1) | Pharmacodynamic activity (1) | pharmacodynamics (2) |
| Pharmacogenetics (1) | Pharmacogenomics (1) | pharmacognostic standardization (1) |
| pharmacognostical (1) | pharmacognosy study (2) | Pharmacokinetic (2) |
| Pharmacokinetic interactions. (1) | pharmacokinetics (7) | Pharmacokinetics. (2) |
| Pharmacological properties (1) | Pharmacovigilance (10) | Pharmacovigilance Programme of India (1) |
| Pharmacovigilance. (1) | Pharmacovigilante’s (1) | pharmacy (4) |
| pharmacy curriculum (2) | Pharmacy education (1) | Pharmacy Enforcement Division (1) |
| Pharmacy informatics (1) | Phase I studies (1) | phase solubility (1) |
| phase solubility profile (1) | Phenobarbitone (1) | phenolic compounds (2) |
| phenolics (1) | phenols (1) | Phenothiazine (1) |
| Phenytoin cold cream (1) | Pheritima posthuma (1) | Phleboliths (1) |
| Phoenix dactylifera (1) | Phosphorylase kinase (1) | Photoprotection. (2) |
| Phthalates (1) | Phyllanthus emblica, (1) | Phylogenetic tree (1) |
| Physical fitness (1) | Physichochemical Characterization (1) | Physicians (3) |
| physicochemical evaluation (1) | physicochemical properties (1) | physiochemical descriptor (1) |
| Phytochemical (2) | phytochemical prospection (1) | picrotoxin (1) |
| pictograms (1) | Pilgrims (1) | PIM (1) |
| Pinus merkusii (1) | pioglitazone (1) | piperazine citrate (1) |
| Piperine (1) | Piroxicam (1) | Pits and Fissures (1) |
| Pixel intensity. (1) | Plackett-Burman (1) | Plackett-Burman design (1) |
| plant extracts (1) | plasma (2) | Plasma concentration (1) |
| plasma concentrations (1) | Plasma creatinine (1) | Plasma insulin (1) |
| Plasma urea (1) | plasma-brain correlation (1) | Plasma. (1) |
| Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) | Platelet aggregation. (1) |
| Platelet rich fibrin membrane. (1) | PLGA (1) | PLSR (1) |
| Pluronic F 127 (1) | Pneumonia (1) | Poisoning pattern (1) |
| Polarography (1) | Poloxamer 188 (1) | Poloxamer 407 (2) |
| Poloxamer 407. (1) | poly (lactic-co-glycolic acid) (1) | poly(ε-caprolactone) (1) |
| polycaprolactone (1) | Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) |
| PolyElectrolytecomplex (1) | Polyherbal (1) | polyherbal formulation (3) |
| Polymeric nanoparticles (1) | polypharmacy (3) | polypharmacy in diabetes mellitus. (1) |
| polyphenols (1) | Polysaccharide (1) | polyvinyl alcohol (2) |
| polyvinyl pyrrolidone (1) | porosity (1) | Positive and Negative stressors (1) |
| Positive coping strategies. (1) | Posology (1) | Possible mechanisms (1) |
| Potassium (1) | Potassium Channel (1) | Potassium chloride (1) |
| Potassium Nitrate (1) | PPAR agonists (1) | pPharmacokinetics (1) |
| PPP model (1) | practice (2) | practices (1) |
| pravastatin (1) | Pre ADMET (1) | pre prandial (1) |
| Pre University students (1) | Pre-authorization (1) | Prebiotic (1) |
| Precipitation (1) | precise (1) | Precision (1) |
| Pregnancy (1) | preliminary screening (2) | Premna esculenta (1) |
| prescriber (1) | Prescribing (1) | Prescribing errors (1) |
| Prescription (3) | Prescription error. (1) | prescription monitoring (1) |
| prescription only medicines (1) | Prescription review (1) | pressure dependent approach (1) |
| Prevalence (3) | Primary health care (2) | Primary Health Care. (1) |
| Principal component analysis (1) | principal component regression (1) | Private Medical College (1) |
| PRO (1) | Probiotic (1) | Probiotics (1) |
| process capability (1) | Process parameters. (1) | Products with Antimicrobial Action. (1) |
| progesterone (1) | Proniosomal gel (1) | propolis (1) |
| Proportional reporting ratio (1) | propranol hydrochloride (1) | Propranolol hydrochloride (1) |
| Prospective Study (1) | prostaglandins (1) | Proteasome activity (1) |
| protein proÞ le (1) | proteolytic enzymes (1) | Proton Pump Inhibitor (2) |
| Proton-pump Inhibitors (1) | Prteomics (1) | Pseudo ternary phase diagrams (1) |
| Pseudomonas aeruginosa (1) | Psidium Guajava (1) | Psychological mindedness (1) |
| Psychomotor (1) | Psychotropics (1) | Pterocarpus indicus (1) |
| Pterocarpus indicus Willd (1) | Publication (1) | Publications (2) |
| Pulmonary Fibrosis (1) | pulmonary hypertension (1) | Punica granatum (1) |
| pyrazine (1) | pyrazoline (1) | pyrazolines (1) |
| Pyrimidine (1) | Q1F (1) | QOL (1) |
| QSAR (2) | qualitative (1) | Qualitative analysis (1) |
| qualitative study (1) | Quality (1) | quality assurance (1) |
| Quality Control (1) | quality of internet information (1) | quality of life (2) |
| quantitative structure-activity relationship (1) | Quercetin (2) | quinazolin-4(3H)one (1) |
| quinazolinone (1) | Quinazolinone. (1) | quinoline derivatives (1) |
| R2 values (1) | Rabbits. (1) | radical scavenger (1) |
| radicals (1) | radiopharmaceuticals (1) | radiopharmacy (1) |
| Radioprotective (1) | Raillietina echinobothrida (1) | raloxifene hydrochloride (1) |
| Raman spectroscopy (1) | ramipril (2) | ranitidine (1) |
| Ranitidine hydrochloride (2) | Ranitidine’. (1) | ranolazine (1) |
| Ransmission electron microscopy (1) | Rapid disintegration (1) | Rasagiline mesylate (1) |
| Rat (1) | ratio test procedures (1) | Rational pharmacotherapy. (1) |
| Rational prescribing (1) | Rational use of medicine (1) | rational use of medicines (1) |
| rats (1) | re-precipitation (1) | recognized standards (1) |
| recovery studies (1) | Red ginger (1) | reforms (1) |
| Regression analysis (1) | Regressions statistics (1) | Regulations (1) |
| regulatory (2) | Regulatory affairs (1) | regulatory system (1) |
| Relative performance (1) | release kinetics (3) | Release studies. (1) |
| relese kinetics (1) | Renoprotection (1) | Renoprotective (1) |
| repaglinide (2) | reperfusion (1) | research (1) |
| Research Skills. (1) | reserpine (1) | Resident doctors (1) |
| Resistance (2) | Response Surface Methodology (1) | Response surface methodology. (1) |
| Resveratrol (2) | retail pharmacy (1) | Retention. (1) |
| reversed-phase chromatography (1) | Rhabdomyolysis (1) | rhizomes (1) |
| Riboflavin (1) | Ringer’s dextrose (1) | Ringer’s lactate. (1) |
| Riociguat (1) | Risk Factors. (1) | rivastigmine (1) |
| RNAi (1) | RNAi technology (1) | RNTCP (1) |
| root (1) | Root canal infection (1) | Ropinirole (1) |
| rosuvastatin (2) | rosuvastatin calcium (1) | Royal Malaysian Custom Officer (1) |
| RP-HPLC (5) | RP-TLC/Densitometry (1) | rupatadine (1) |
| rutin (1) | ß avonoids (2) | S. mutans (1) |
| S.salivarius (1) | S.sanguis (1) | Saccharin (1) |
| Safe handling guidelines (1) | Safety (1) | saponins (1) |
| Sappan wood (1) | Saraschandra (1) | Saudi Arabia (1) |
| scanning electron microscopy (3) | Scientific Advertisements (1) | Scientometrics (3) |
| sclerotherapy (1) | Scores. (1) | Se- DeM ODT Expert system (1) |
| Secondary Level (1) | seizure outcome (1) | Selected area electron diffraction (1) |
| Self medication (1) | self-emulsifying drug delivery system (1) | self-medication (4) |
| self-nanoemulsification (1) | senna spectabilis (1) | sensory cortical activity. (1) |
| separation (1) | sepbox (1) | Sequential optimization (1) |
| Serum triglyceride (1) | Serum. (1) | sesame oil (1) |
| severe febrile neutropenia (1) | Shodhana (1) | Short Communication (3) |
| short-term memory (1) | Sida rhomboidea.Roxb (1) | Side effect (1) |
| Signal detection. (1) | silymarin (1) | similarity factor (f2) (2) |
| simplex lattice (1) | Simplex Lattice Design (1) | simultaneous determination (2) |
| simultaneous extraction (1) | simvastatin (1) | simvastatin. (1) |
| Single nucleotide polymorphism (1) | sintering (1) | siRNA (1) |
| siRNA. (2) | six sigma (1) | SJS (1) |
| SLS (1) | Smix. (1) | Smoking (1) |
| smoking cessation. (1) | Smoking. (1) | smooth muscle cells (1) |
| Snake bite (1) | SNEDDS (2) | sobatum (1) |
| Social Media (1) | Social sexual. (1) | Sodium (1) |
| sodium alginate (1) | sodium alginate. (1) | sodium carboxy methyl cellulose (1) |
| sodium starch glycolate (3) | Sodium starch glycolate (SSG) (1) | Solanum nigrum (1) |
| Solanum trilobatum (1) | Solanum xanthocarpum, (1) | solid dispersion (4) |
| solid lipid nanoparticles (1) | Solid lipid nanoparticles. (1) | solubility (5) |
| Solubility enhancement (1) | Solubility. (1) | solvent casting (1) |
| solvent evaporation (3) | sonication time (1) | sonophoresis (1) |
| spasmolytic (1) | speciÞ city (1) | Spectrometric (1) |
| spectrophotometry (2) | sperm count (1) | Spiro compounds (1) |
| Spleen colony assay (1) | sponge implantation assay (1) | sponsors (1) |
| Spontaneous-Reporting. (1) | Sprague Dawley (1) | spray drying (1) |
| stability (1) | stability indicating (1) | stability indicating and validation. (1) |
| Stability indicating assay (1) | Stability indicating assay method (1) | stability indicating method of artemether (1) |
| Stability of the physical properties (1) | stability. (1) | stain removal (1) |
| stakeholders (1) | Standardization (5) | Staphylococcus aureus (1) |
| Starlac (1) | Statin pathway (1) | Statins. (1) |
| Statistical Modeling (1) | Statistical optimization (1) | Stem bark extract (1) |
| Stephania hernandifolia (1) | Stereospermum suaveolens (1) | Stereospermum tetragonum (2) |
| Steudnera colocasiifolia (1) | Stevens-Johnson syndrome (1) | Stilbene (1) |
| Stimulantia (1) | Streptococcus mutans (2) | Streptomonospora arabica (1) |
| Streptomyces (1) | Streptozotocin (2) | Streptozotocin (STZ) (1) |
| streptozotocin-induced diabetes (1) | Streptozotocin. (1) | stress (3) |
| stress studies (2) | stroke and cardiac pacemaker. (1) | Stroke prevention (1) |
| structural descriptor (1) | Structured Communication. (1) | Stryphnodendron rotundifolium (1) |
| students (2) | students’ residence (1) | Sub Clinical Hypothyroidism. (1) |
| Sub-acute Inflammation (1) | sublingual films (1) | substituted acetophenones (1) |
| sucrase (1) | Sudan (1) | Sulfonylurea (2) |
| Sulphorhodamine-B (1) | Sun (1) | sun protection factor (2) |
| Sunscreens. (1) | Super disintegrants (1) | superdisintegrants (2) |
| Superdisintergrants (1) | Superoxide Dismutase. (1) | superoxidedismutase (1) |
| superporous hydrogel composite (1) | support staff. (1) | Surface properties (1) |
| surfactant (1) | surfactants (1) | surgical prophylaxis. (1) |
| Surgical. (1) | Survey questionnaire (1) | survey. (1) |
| Survival rate (1) | sustained release (3) | sustained release pellets (1) |
| sustained release. (1) | swelling index (1) | swelling studies (1) |
| Synchronous spectrofluorimetry. (1) | Synergism. (1) | Synthesis (1) |
| Systematic Review. (1) | Systems biotechnology (1) | Tablet Compression (1) |
| Tacrolimus Once Daily (1) | Tacrolimus Twice Daily. (1) | Tactile stimulation (1) |
| tail suspension test (1) | Tamarindus indica (1) | Tamilians (1) |
| Tamoxifen (1) | Targeted drug delivery system (1) | taste masking (2) |
| tasteless complex (1) | taxane (1) | Taxus baccata (1) |
| Teaching Hospital (1) | Technology (1) | technology-enhanced learning (1) |
| tegument (1) | telmisartan (1) | TEN (1) |
| Tenofovir disoproxil fumarate (1) | Tephrosia purpurea ethanolic seed extract (TpEt). (1) | Terminalia bellirica (1) |
| Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) | terpenoids (1) | Tertiary Care (1) |
| Tertiary care hospital (2) | testicular damage (1) | testosterone (2) |
| Tetrapreniltoluquinone (1) | therapeutic angiogenesis (1) | therapeutic dose (1) |
| therapeutic drug monitoring (1) | therapeutic effectiveness (1) | Thermoreversible gel (1) |
| Thrombolytic (1) | thrombolytic enzymes (1) | Thyrotoxicosis. (1) |
| time dependent approach (1) | Time lag (1) | Timed release (1) |
| Tobacco (1) | Tobacco smoking (1) | tolbutamide (1) |
| Tolerance (1) | Tooth brush. (1) | Toothpaste. (1) |
| Topical delivery. (1) | Topical. (1) | Total flavonoid (1) |
| Total phenolic (1) | total polyphenolic content (1) | total quality management (1) |
| toxicity (1) | Toxicity. (2) | traditional medicine (2) |
| tramadol HCL (1) | Tramadol Hydrochloride (1) | Trans-cinnamic acid (1) |
| Trans-resveratrol (1) | Transcriptomics. (1) | transdermal (2) |
| transfer latency (1) | Transmucosal (1) | Transmucosal patch (1) |
| Treatment adherence. (1) | Treatment outcomes (1) | Triacylglycerol. (1) |
| Triamcinalone Acetonide (TRIA) (1) | Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) |
| Triglycerides (1) | Trigonella foenum graecum (1) | Trigonelline (1) |
| Trinidad & Tobago (1) | trinitrobenzene sulfonic acid (1) | Triphala (1) |
| triple distilled water (1) | Triterpenoid. (1) | Triterpenoids (1) |
| Triticum aestivum. (1) | Tropaeolum majus L (1) | tropicamide (1) |
| Troponin-I (1) | Trypsin (1) | Tuberculosis (1) |
| Tumor response (1) | Tween 80. (1) | Twisted (1) |
| Tylophora indica (1) | Tylophorinidine. (1) | type 2 diabetes (2) |
| type 2 diabetes. (1) | UACR (1) | UCPMP Guidelines (1) |
| ultrasonication-solvent evaporation technique (1) | Uncemented (1) | Underutilization of insulin. (1) |
| Unethical practices. (1) | Unique device identification (1) | Universities (1) |
| Unlicensed. (1) | Unnecessary use. (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) |
| Urban area (1) | urea (1) | Urinary Hydrogen Peroxide (1) |
| Urinary tract infection (UTI) (1) | Urine Albumin to Creatinine Ratio (1) | Urine volume (1) |
| urolithiasis (1) | Urtica dioica L (1) | Usefulness. (1) |
| Uterine fibroid (1) | Uterine Perforation. (1) | UV derivative spectrophotometry (1) |
| UV detection (2) | UV Spectrophotometric method (1) | UV spectrophotometry (1) |
| UV-spectrophotometric method (1) | UV-spectrophotometry (2) | vada (1) |
| vaginal gel (1) | Vaginitis. (1) | validation (13) |
| Valium (1) | Valproate (1) | valsartan (1) |
| Vanillin (1) | Vanillosmopsis arborea. (1) | vascular bundle (1) |
| vascular permeability (2) | vascular progenitors (1) | VED analysis (2) |
| VED analysis. (1) | Venography and Hemangioma (1) | Venous malformations (VMs) (1) |
| verapamil (3) | Verapamil HCl (1) | Vincristine. (1) |
| visible Spectrophotometry (1) | visible spectroscopy (1) | Visual analogue scale. (1) |
| Vitamin D deficiency (1) | Vitamin D. (1) | vitamin E (1) |
| vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) | Vitamin. (1) | Vitex agnus Castus (1) |
| Voltage–gated calcium channels (1) | warfarin (2) | Water hyacinth (1) |
| web-based learning (1) | Weibull parameters (1) | wet granulation (1) |
| wetting time (1) | Wheat (1) | WHO-QOL BREF questionnaire (1) |
| WHO-UMC causality assessment system. (1) | Wistar rats. (1) | Withania somnifera. (1) |
| Withdrawal (1) | Women. (1) | Work protection (1) |
| Wrightia tinctoria (1) | writhing (1) | X-ray diffraction (1) |
| X-ray imaging study. (1) | X-ray powder diffraction (1) | xanthan gum (1) |
| Xanthangum (1) | XDR-TB (1) | Xenografts (1) |
| Xenografts. (1) | XRD (1) | Yucca gloriosa L. (1) |
| Zero order release (1) | zero order spectrophotometry (1) | zeta potential (1) |
| zidovudine (1) | Zika virus (1) | Zingiberaceae (1) |
| zopiclone (1) | [BMIM]PF6 (1) | Þ rst-order derivative spectroscopy (1) |
| Α-amylase (2) | α-glucosidase (1) | β Amyloid1-42 (1) |
| β-carboline (1) | β-carotene production (1) | β-cyclodextrin (2) |
| γ-oryzanol (1) | ε-amino groups (1) | |
